FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891903936> ?p ?o ?g. }

• W2891903936 endingPage "4372" @default.
• W2891903936 startingPage "4365" @default.
• W2891903936 abstract "Diazoxide, the only U.S. Food and Drug Administration–approved drug to treat hyperinsulinemic hypoglycemia, has been associated with several adverse events, which has raised concerns about the safety of this drug. Existing reports are limited to small studies and case reports. To determine prevalence of and clinical factors associated with adverse events in infants and children treated with diazoxide. Retrospective cohort study of children with hyperinsulinism (HI) treated with diazoxide between 2003 and 2014. The Congenital Hyperinsulinism Center at the Children’s Hospital of Philadelphia. Children and infants with laboratory-confirmed diagnosis of HI. Prevalence of pulmonary hypertension (PH), edema, neutropenia, thrombocytopenia, and hyperuricemia was determined. Tests of association and logistic regression were used to identify potential risk factors. A total of 295 patients (129 female) met inclusion criteria. The median age at diazoxide initiation was 29 days (interquartile range, 10 to 142 days; n = 226 available start dates); 2.4% of patients were diagnosed with PH after diazoxide initiation. Children with PH (P = 0.003) or edema (P = 0.002) were born at earlier gestational age and more frequently had potential PH risk factors, including respiratory failure and structural heart disease (P < 0.0001 and P = 0.005). Other adverse events included neutropenia (15.6%), thrombocytopenia (4.7%), and hyperuricemia (5.0%). In this large cohort, PH occurred in infants with underlying risk factors, but no identifiable risk profile emerged for other adverse events. The relatively high prevalence of neutropenia, thrombocytopenia, and hyperuricemia suggests the value in proactively screening for these side effects in children treated with diazoxide." @default.
• W2891903936 created "2018-09-27" @default.
• W2891903936 creator A5009803036 @default.
• W2891903936 creator A5012462287 @default.
• W2891903936 creator A5049083394 @default.
• W2891903936 creator A5051617679 @default.
• W2891903936 creator A5053317650 @default.
• W2891903936 creator A5056739487 @default.
• W2891903936 creator A5065959059 @default.
• W2891903936 date "2018-09-21" @default.
• W2891903936 modified "2023-10-15" @default.
• W2891903936 title "Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide" @default.
• W2891903936 cites W1891268586 @default.
• W2891903936 cites W1933653460 @default.
• W2891903936 cites W1978663685 @default.
• W2891903936 cites W1987076711 @default.
• W2891903936 cites W1988775252 @default.
• W2891903936 cites W2016657294 @default.
• W2891903936 cites W2038353863 @default.
• W2891903936 cites W2047843056 @default.
• W2891903936 cites W2050708063 @default.
• W2891903936 cites W2053875866 @default.
• W2891903936 cites W2056798703 @default.
• W2891903936 cites W2076523697 @default.
• W2891903936 cites W2079456780 @default.
• W2891903936 cites W2115515282 @default.
• W2891903936 cites W2122004372 @default.
• W2891903936 cites W2148647537 @default.
• W2891903936 cites W2164373447 @default.
• W2891903936 cites W2164805913 @default.
• W2891903936 cites W2168895815 @default.
• W2891903936 cites W2173795324 @default.
• W2891903936 cites W2187658469 @default.
• W2891903936 cites W2711821057 @default.
• W2891903936 cites W2739016158 @default.
• W2891903936 cites W4236272472 @default.
• W2891903936 doi "https://doi.org/10.1210/jc.2018-01613" @default.
• W2891903936 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6207144" @default.
• W2891903936 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30247666" @default.
• W2891903936 hasPublicationYear "2018" @default.
• W2891903936 type Work @default.
• W2891903936 sameAs 2891903936 @default.
• W2891903936 citedByCount "62" @default.
• W2891903936 countsByYear W28919039362019 @default.
• W2891903936 countsByYear W28919039362020 @default.
• W2891903936 countsByYear W28919039362021 @default.
• W2891903936 countsByYear W28919039362022 @default.
• W2891903936 countsByYear W28919039362023 @default.
• W2891903936 crossrefType "journal-article" @default.
• W2891903936 hasAuthorship W2891903936A5009803036 @default.
• W2891903936 hasAuthorship W2891903936A5012462287 @default.
• W2891903936 hasAuthorship W2891903936A5049083394 @default.
• W2891903936 hasAuthorship W2891903936A5051617679 @default.
• W2891903936 hasAuthorship W2891903936A5053317650 @default.
• W2891903936 hasAuthorship W2891903936A5056739487 @default.
• W2891903936 hasAuthorship W2891903936A5065959059 @default.
• W2891903936 hasBestOaLocation W28919039361 @default.
• W2891903936 hasConcept C119060515 @default.
• W2891903936 hasConcept C126322002 @default.
• W2891903936 hasConcept C167135981 @default.
• W2891903936 hasConcept C187212893 @default.
• W2891903936 hasConcept C197934379 @default.
• W2891903936 hasConcept C2777368190 @default.
• W2891903936 hasConcept C2777391703 @default.
• W2891903936 hasConcept C2779306644 @default.
• W2891903936 hasConcept C2779721657 @default.
• W2891903936 hasConcept C2779872217 @default.
• W2891903936 hasConcept C2779881121 @default.
• W2891903936 hasConcept C2780668416 @default.
• W2891903936 hasConcept C71924100 @default.
• W2891903936 hasConcept C72563966 @default.
• W2891903936 hasConceptScore W2891903936C119060515 @default.
• W2891903936 hasConceptScore W2891903936C126322002 @default.
• W2891903936 hasConceptScore W2891903936C167135981 @default.
• W2891903936 hasConceptScore W2891903936C187212893 @default.
• W2891903936 hasConceptScore W2891903936C197934379 @default.
• W2891903936 hasConceptScore W2891903936C2777368190 @default.
• W2891903936 hasConceptScore W2891903936C2777391703 @default.
• W2891903936 hasConceptScore W2891903936C2779306644 @default.
• W2891903936 hasConceptScore W2891903936C2779721657 @default.
• W2891903936 hasConceptScore W2891903936C2779872217 @default.
• W2891903936 hasConceptScore W2891903936C2779881121 @default.
• W2891903936 hasConceptScore W2891903936C2780668416 @default.
• W2891903936 hasConceptScore W2891903936C71924100 @default.
• W2891903936 hasConceptScore W2891903936C72563966 @default.
• W2891903936 hasFunder F4320337357 @default.
• W2891903936 hasIssue "12" @default.
• W2891903936 hasLocation W28919039361 @default.
• W2891903936 hasLocation W28919039362 @default.
• W2891903936 hasLocation W28919039363 @default.
• W2891903936 hasLocation W28919039364 @default.
• W2891903936 hasOpenAccess W2891903936 @default.
• W2891903936 hasPrimaryLocation W28919039361 @default.
• W2891903936 hasRelatedWork W1431662074 @default.
• W2891903936 hasRelatedWork W1993464873 @default.
• W2891903936 hasRelatedWork W2092981366 @default.
• W2891903936 hasRelatedWork W2170664340 @default.
• W2891903936 hasRelatedWork W2328432683 @default.

• next